Internal Reference Number: FOI_7884
Date Request Received: 12/04/2024 00:00:00
Date Request Replied To: 29/04/2024 00:00:00
This response was sent via: By Email
Request Summary: Biliary Tract and Non-Small Cell Lung Cancer Treatment
Request Category: Private Individuals
| Question Number 1: I would be grateful if you could please provide the following information with regards to patients treated with Durvalumab (Imfinzi) and Nivolumab. Where the specified Nov 23 – March 24 timeframe is not possible to provide, could you please provide the latest 5 months of data you have, and specify which timeframe this covers. 1. How many unique total patients were treated in the last 5 months (Nov 23 – March 24) with Durvalumab for the following indications? A) Biliary Tract Cancer B) Non-Small Cell Lung Cancer | |
| Answer To Question 1: A) Biliary Tract Cancer 0 Patients treated B) Non-Small Cell Lung Cancer <5 patients treated | |
| Question Number 2: How many unique total patients were treated in the last 5 months (Nov 23 – March 24) with Nivolumab for early stage (resectable) non-small cell lung cancer (Stages 1 – 3b). | |
| Answer To Question 2: <5 patients treated | |
| Question Number 3: How many unique total patients were treated last month (March 24) with Durvalumab for the following indications? C) Biliary Tract Cancer D) Non-Small Cell Lung Cancer | |
| Answer To Question 3: C) Biliary Tract Cancer 0 patients treated D) Non-Small Cell Lung Cancer <5 patients treated | |
| Question Number 4: How many patients received their first treatment in the last 5 months (Nov 23 – March 24) with Durvalumab for the following indications? E) Biliary Tract Cancer F) Non-Small Cell Lung Cancer | |
| Answer To Question 4: E) Biliary Tract Cancer 0 patients treated F) Non-Small Cell Lung Cancer <5 patients treated | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
